metoprololsuccinat "hexal" 100 mg depottabletter
hexal a/s - metoprololsuccinat - depottabletter - 100 mg
metoprololsuccinat "hexal" 200 mg depottabletter
hexal a/s - metoprololsuccinat - depottabletter - 200 mg
metoprololsuccinat "hexal" 50 mg depottabletter
hexal a/s - metoprololsuccinat - depottabletter - 50 mg
nebivolol "orion" 5 mg tabletter
orion corporation - nebivololhydrochlorid - tabletter - 5 mg
nebicare 5 mg tabletter
2care4 aps - nebivololhydrochlorid - tabletter - 5 mg
metoprololsuccinat "1a farma" 100 mg depottabletter
1a farma a/s - metoprololsuccinat - depottabletter - 100 mg
metoprololsuccinat "1a farma" 200 mg depottabletter
1a farma a/s - metoprololsuccinat - depottabletter - 200 mg
metoprololsuccinat "1a farma" 50 mg depottabletter
1a farma a/s - metoprololsuccinat - depottabletter - 50 mg
stromolol 2,5 mg filmovertrukne tabletter
aristo pharma gmbh - bisoprololfumarat - filmovertrukne tabletter - 2,5 mg
daklinza
bristol-myers squibb pharma eeig - daclatasvir dihydrochlorid - hepatitis c kronisk - antivirale midler til systemisk anvendelse - daklinza er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c virus (hcv) infektion hos voksne (se afsnit 4. 2, 4. 4 og 5. for hcv-genotype specifik aktivitet, se afsnit 4. 4 og 5.